FDA Clearance Tracker · K254010
ExacTrac Dynamic (2.0.2); ExacTrac Dynamic Surface
Last checked: Nov 19, 2026Latest source record: Jan 14, 2026 (this decision)Source: openFDAMethods & limitations
Decided
Jan 14, 2026
Substantially Equivalent
Time to decision
30 days
Received Dec 15, 2025. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Special
Device class
Class II
The decision
- FDA number
- K254010
- Device name
- ExacTrac Dynamic (2.0.2); ExacTrac Dynamic Surface
- Applicant
- Brainlab SE
- Applicant location
- Munich, DE
- Received
- Dec 15, 2025
- Decided
- Jan 14, 2026
- Decision
- Substantially Equivalent
- Submission type
- Special
Device type
- Device type
- Accelerator, Linear, Medical (IYE)
- Device class
- Class II
- Regulation
- 21 CFR 892.5050
- Specialty
- Radiology & Imaging
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code IYE. The earliest in FDA's data is K771260, decided Aug 3, 1977.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K254010
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Brainlab SE
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- RT Elements (4.6)510(k)
K261655 · Decided Oct 5, 2026 · 139 days after receipt
Device type: System, Planning, Radiation Therapy Treatment (MUJ) · Radiology & Imaging
K262257 · Decided Sep 30, 2026 · 90 days after receipt
Device type: Orthopedic Stereotaxic Instrument (OLO) · Neurology & Neurosurgery
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.